A modified herpes virus that targets spinal cord nerve cells to treat neurogenic bladder in people with spinal cord injury is underway in a first-in-human clinical trial by UTHealth Houston at TIRR Memorial Hermann.
Rimidi Enhances Integration with Dexcom, Adds Glycemic Risk Index to Diabetes Platform
What You Should Know: Rimidi, a clinical management platform designed to optimize clinical workflows, enhance patient experiences and achieve quality objectives, is announcing enhancements to